Security key
09090D301
BiomX Inc. - Common Stock, $0.0001 par value (PHGE)
CUSIP: 09090D301
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 8,754,926
- Total 13F value
- $8,930,525
- Share change
- +8,165,899
- SEC-reported price per share
- $1.02
- Number of holders
- 13
- Value change
- +$8,329,717
- Number of buys
- 12
- Shares outstanding
- 1,527,040
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
13
Top holders
10
PHGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
BiomX Inc. SEC filings
BiomX Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09090D301
Recent filing periods:
Ownership snapshot
Top reported holders of PHGE - BiomX Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
OrbiMed Israel BioFund GP...
Comparable rows
10/15
Latest evidence
16 Sep 2024
13F
3/4/5
Lead comparable stake: 867%
5 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 867%.
10 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
867%
DEERFIELD MANAGEMENT COMPANY, L.P.
385%
JOHNSON & JOHNSON
121%
8VC GP I, LLC
68%
BARCLAYS PLC
16%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
867%
|
$4,629,325
13,773,653 shares
|
— | 30 Jun 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
385%
|
$2,053,604
6,110,098 shares
|
— | 30 Jun 2024 |
| JOHNSON & JOHNSON |
13F
Company
|
121%
|
$646,388
1,923,201 shares
|
— | 30 Jun 2024 |
| 8VC GP I, LLC |
13F
Company
|
68%
|
$365,069
1,086,191 shares
|
— | 30 Jun 2024 |
| BARCLAYS PLC |
13F
Company
|
16%
|
$84,025
250,000 shares
|
— | 30 Jun 2024 |
| UBS Group AG |
13F
Company
|
3.1%
|
$16,398
48,805 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
8,754,926
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q3 2025 Across Filers
Q3 2025 holders
16
Q3 2024 holders
13
Holder diff
-3
| Investor | Q3 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend